SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-023853
Filing Date
2021-02-16
Accepted
2021-02-16 16:01:44
Documents
2
Group Members
KAIJING YANTASLY BIOPHARM LTDTASLY HOLDING GROUP CO., LTD.TASLY INTERNATIONAL BIOINV ONE LTDTASLY PHARMACEUTICAL GROUP CO., LTD.TIANJIN FUHUADE SCIENCE & TECHNOLOGY DEVELOPMENT CO., LTD.TIANJIN TASLY HEALTH INDUSTRY INVESTMENT GROUP CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G a21-6270_1sc13g.htm SC 13G 267830
2 EX-99.1 a21-6270_1ex99d1.htm EX-99.1 35248
  Complete submission text file 0001104659-21-023853.txt   305012
Mailing Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210
Business Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210 862160578000
I-Mab (Subject) CIK: 0001778016 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91674 | Film No.: 21637817
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 JULI ROAD PILOT FREE TRADE ZONE SHANGHAI F4 201203
Business Address 280 JULI ROAD PILOT FREE TRADE ZONE SHANGHAI F4 201203 0086-21-61052887
Tasly Biopharmaceuticals Co., Ltd. (Filed by) CIK: 0001846243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G